Correction: Overall survival of palbociclib plus endocrine therapy in Japanese patients with HR+/HER2− advanced breast cancer in the first-or second-line setting: a multicenter observational study (P-BRIDGE study)
本文未提供摘要,请点击“查看全文”查看完整内容。